From 11b4166efacf7eb4dfc2970d3d13840d57060e61 Mon Sep 17 00:00:00 2001 From: Syl Lutze Date: Tue, 14 Nov 2023 09:07:24 -0500 Subject: [PATCH] Typos --- .../models/intervention_models/crm_mgmt/vivarium_polypill.rst | 4 ++-- 1 file changed, 2 insertions(+), 2 deletions(-) diff --git a/docs/source/models/intervention_models/crm_mgmt/vivarium_polypill.rst b/docs/source/models/intervention_models/crm_mgmt/vivarium_polypill.rst index 4e92885c4..05f15a58a 100644 --- a/docs/source/models/intervention_models/crm_mgmt/vivarium_polypill.rst +++ b/docs/source/models/intervention_models/crm_mgmt/vivarium_polypill.rst @@ -131,8 +131,8 @@ treatment effect component (e.g., matches the other parts of this model). The polypill includes: - Amlodipine where the standard dose is 5 mg. Our polypill uses half standard dose or 2.5 mg. - Losartan where the standard dose is 50 mg. Our polypill uses half standard dose or 25 mg. -- Hydrochlorothiazide is not used in isolation in the UK but is simialr to chlorthalidone in action and dosing, which has a standard dose of 25 mg. Our polypill uses half standard dose so that would map to 12.5 mg. -- [Munoz-NEJM]_ includes atorvastatin as well which we would be ignoring. This limitation was noting and discussed with Greg. +- Hydrochlorothiazide is not used in isolation in the UK but is similar to chlorthalidone in action and dosing, which has a standard dose of 25 mg. Our polypill uses half standard dose so that would map to 12.5 mg. +- [Munoz-NEJM]_ includes atorvastatin as well which we would be ignoring. This limitation was noted and discussed with Greg. Assumptions and Limitations